Modulators of alpha-1 antitrypsin

Upul Keerthi Bandarage, Lexington, MA (US);

Cavan McKeon Bligh, Melrose, MA (US);

Michael John Boyd, Sharon, MA (US);

Diane M. Boucher, South Hamilton, MA (US);

Michael Aaron Brodney, Newton, MA (US);

Veronique Damagnez, Boston, MA (US);

Lev Tyler Dewey Fanning, San Marcos, CA (US);

Mary Elizabeth Eccles, Cambridge, MA (US);

Robert Francis Fimognari, Jr., Brookline, MA (US);

Kevin James Gagnon, Burlington, MA (US);

Pedro M. Garcia Barrantes, Melrose, MA (US);

Simon Giroux, Cambridge, MA (US);

Ronald Lee Grey, Jr., Mansfield, MA (US);

Amy Beth Hall, Wellesley Hills, MA (US);

Sarah Carol Hood, Worchester, MA (US);

Dennis James Hurley, San Marcos, CA (US);

Joshua Kennedy Hussey, Pepperell, MA (US);

Mac Arthur Johnson, Jr., Derry, NH (US);

Peter Jones, Sharon, MA (US);

Sarathy Kesavan, Quincy, MA (US);

Adam Looker, Aurburndale, MA (US);

Brad D. Maxwell, Holliston, MA (US);

John Patrick Maxwell, Hingham, MA (US);

Ales Medek, Winchester, MA (US);

Mettachit Navamal, Belmont, MA (US);

Philippe Marcel Nuhant, Dorchester, MA (US);

Setu Roday, Arlington, MA (US);

Stefanie Roeper, Medford, MA (US);

Rupa Sawant, Wayland, MA (US);

Yi Shi, Natick, MA (US);

Rebecca Jane Swett, Somerville, MA (US);

Qing Tang, Boxborough, MA (US);

Timothy Lewis Tapley, Cardiff, CA (US);

Stephen A. Thomson, Del Mar, CA (US);

Michael Waldo, Grafton, MA (US);

Jinwang Xu, Framingham, MA (US);

Kevin Michael Cottrell, Cambridge, MA (US);

Vertex Pharmaceuticals Incorporated, Boston, MA (US);